BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11722575)

  • 1. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
    Dall'Olio F; Chiricolo M; Mariani E; Facchini A
    Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-galactoside alpha2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin.
    Dall'Olio F; Chiricolo M; Ceccarelli C; Minni F; Marrano D; Santini D
    Int J Cancer; 2000 Oct; 88(1):58-65. PubMed ID: 10962440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro.
    Zhu Y; Srivatana U; Ullah A; Gagneja H; Berenson CS; Lance P
    Biochim Biophys Acta; 2001 May; 1536(2-3):148-60. PubMed ID: 11406350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the hepatic transcript of beta-galactoside alpha2,6-sialyltransferase in human colon cancer cell lines.
    Dall'Olio F; Chiricolo M; Lau JT
    Int J Cancer; 1999 Apr; 81(2):243-7. PubMed ID: 10188726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-galactoside alpha2,6-sialyltransferase and the sialyl alpha2,6-galactosyl-linkage in tissues and cell lines.
    Dall'Olio F; Malagolini N; Chiricolo M
    Methods Mol Biol; 2006; 347():157-70. PubMed ID: 17072010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.
    Lee M; Park JJ; Ko YG; Lee YS
    Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha 2,6 sialyltransferase cDNA.
    Dall'Olio F; Chiricolo M; Lollini P; Lau JT
    Biochem Biophys Res Commun; 1995 Jun; 211(2):554-61. PubMed ID: 7794269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.
    Chiricolo M; Malagolini N; Bonfiglioli S; Dall'Olio F
    Glycobiology; 2006 Feb; 16(2):146-54. PubMed ID: 16192407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis.
    Dall'Olio F; Mariani E; Tarozzi A; Meneghetti A; Chiricolo M; Lau JT; Facchini A
    Glycobiology; 1997 Jun; 7(4):507-13. PubMed ID: 9184831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells.
    Lin S; Kemmner W; Grigull S; Schlag PM
    Exp Cell Res; 2002 May; 276(1):101-10. PubMed ID: 11978012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene.
    Jones MB; Nasirikenari M; Lugade AA; Thanavala Y; Lau JT
    J Biol Chem; 2012 May; 287(19):15365-70. PubMed ID: 22427662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.
    Dall'Olio F; Chiricolo M; D'Errico A; Gruppioni E; Altimari A; Fiorentino M; Grigioni WF
    Glycobiology; 2004 Jan; 14(1):39-49. PubMed ID: 14514712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ST6Gal I siRNA and antisense oligonucleotide-mediated gene silencing lowers the invasiveness potential of colonic carcinoma cells].
    Yuan TH; Li MY; Li WY; Li H; Jiang ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):136-40. PubMed ID: 17355919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.
    Appenheimer MM; Huang RY; Chandrasekaran EV; Dalziel M; Hu YP; Soloway PD; Wuensch SA; Matta KL; Lau JT
    Glycobiology; 2003 Aug; 13(8):591-600. PubMed ID: 12672700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts.
    Dalziel M; Lemaire S; Ewing J; Kobayashi L; Lau JT
    Glycobiology; 1999 Oct; 9(10):1003-8. PubMed ID: 10521536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of alpha2,6-sialylated lactosaminic chains marks apoptotic and necrotic death in different cell types.
    Malagolini N; Chiricolo M; Marini M; Dall'Olio F
    Glycobiology; 2009 Feb; 19(2):172-81. PubMed ID: 18988689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.
    Dalziel M; Dall'Olio F; Mungul A; Piller V; Piller F
    Eur J Biochem; 2004 Sep; 271(18):3623-34. PubMed ID: 15355339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation.
    Dalziel M; Huang RY; Dall'Olio F; Morris JR; Taylor-Papadimitriou J; Lau JT
    Glycobiology; 2001 May; 11(5):407-12. PubMed ID: 11425801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
    Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.
    Seales EC; Jurado GA; Brunson BA; Wakefield JK; Frost AR; Bellis SL
    Cancer Res; 2005 Jun; 65(11):4645-52. PubMed ID: 15930282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.